Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. has been discovered 6 times, most recently on Sep 17, 2026. 50% of those picks are up, with an average return of 4.75%. View on Yahoo Finance ↗
Total picks6
Win rate50.0%Up 3 · Down 3 · Flat 0
Avg. return+4.75%Median +4.56%
Best / Worst+25.8% / -10.0%
Advertisement
✅ Latest summary (Sep 17, 2026)
Gilead Sciences, Inc. focuses on innovative therapeutics in areas such as HIV, liver diseases, and oncology. The company reported robust earnings recently, driven by strong sales of its key products. With a significant market capitalization, GILD remains a prominent player in the biotech industry.
View details →📅 Discovery history
| Discovered | Discovery price | Current price | Return | |
|---|---|---|---|---|
| Sep 17, 2026 | $150.89 | $168.08 | +11.39% | View details |
| Aug 12, 2026 Archived | $135.87 | $170.87 | +25.76% | View details |
| May 6, 2026 Archived | $136.30 | $135.25 | -0.77% | View details |
| Apr 1, 2026 Archived | $140.30 | $126.34 | -9.95% | View details |
| Jan 30, 2026 Archived | $141.95 | $130.84 | -7.83% | View details |
| Dec 24, 2025 Archived | $125.67 | $138.11 | +9.90% | View details |
Advertisement